Assessing gait and balance in rare neurological diseases
Official title: Gait and Balance Impairment in Rare and Very Rare Neurological Diseases
Run by Istituto Auxologico Italiano · NCT06343558 · Data updated 2026-11-12
This study looks at how walking and balance are affected in people with rare neurological diseases to better understand their challenges and risks of falling.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Istituto Auxologico Italiano Academic / other |
| Locations | 2 sites (Milan, Milan and 1 other locations) |
| Status | Recruiting |
| Started | May 30, 2023 |
| Main results expected | May 1, 2027 |
| Study ends | May 1, 2027 |
| Registry record updated | August 3, 2025 |
| Trial ID | NCT06343558 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults over 18 with multiple sclerosis, Parkinson's disease, peripheral neuropathy, or other rare neurological conditions.
✕Probably not a fit
Patients with conditions affecting balance and gait due to other medical issues, such as lower limb amputation or recent major orthopedic surgery, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on individuals with rare and very rare neurological diseases, including conditions like multiple sclerosis and Parkinson's disease. It aims to evaluate gait and balance impairments that are common in these conditions, which can lead to increased fall risk and injuries. Participants will undergo assessments using questionnaires, clinical scales, and instrumental tests to gather essential data on their motor functions. The study seeks to improve understanding of these diseases, which are often poorly characterized due to their rarity.
Why it matters
Potential benefit: If successful, this study could enhance diagnosis and treatment strategies for patients with rare neurological diseases.
How similar studies have gone: While there are few studies on rare neurological diseases, existing research has shown that understanding gait and balance can lead to better management of these conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria * Multiple sclerosis, Parkinson's disease, peripheral neuropathy of the lower limbs or rare or ultrarare neurological disease (e.g. la Cerebellar Ataxia with Neuropathy and Vestibular Areflexia Syndrome - CANVAS, ORPHAcode: 504476; Wilson's disease, ORPHAcode: 905) * undiagnosed neurological disease, i.e. a neurological disease that remains unknown after a full diagnostic assessment; * age \> 18 years; * ability to stand upright with no assistance and no assistive device for \> 30 seconds; * ability to walk without assistance and with no assistive device for \> 50 m; * ability to give their informed consent. Exclusion criteria * pregnancy or breastfeeding * any other medical conditions affecting by itself balance and gait (e.g. lower limb amputation, hemiparesis due to a stroke) * major orthopaedic surgery (e.g. hip or knee replacement).
Where it's running
-
IRCCS Istituto Auxologico Italiano
Milan, Milan, Italy Recruiting -
IRCCS Istituto Neurologico Carlo Besta
Milan, Italy Active not recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using ultra-high field and metabolic MRI to understand resilience and degeneration in the aging and diseased brain
This project will try advanced 3T and 7T MRI scans, including sodium and phosphorus imaging, to see if metabolic and connectivity changes explain resilience and degeneration in adults with MS, NMOSD, MOGAD, Alzheimer’s, Parkinson’s, or healthy aging.
-
OCT in Neurological Practice: Use of Retinal Layers to Help Diagnose and Follow Neurological Diseases
This study tests whether optical coherence tomography (OCT) of the retina can help in diagnosing and tracking multiple sclerosis, Alzheimer's, Parkinson's, migraines, and other headaches compared with healthy people.
-
Early detection of neuropathologies affecting drivers
This project tests whether simple clinical and motor/cognitive tests can spot early signs of multiple sclerosis or Parkinson's disease that affect people who drive.
-
Motor learning with physical activity and advanced devices in healthy people and movement disorders
This study tests whether combining traditional physical activity with advanced devices and immersive therapy helps improve motor skills and functional recovery in healthy individuals and people with movement disorders.
-
Telehealth rehabilitation for neurodegenerative diseases
This study is testing if online rehabilitation programs can help people with Parkinson's Disease and Multiple Sclerosis feel better compared to traditional education methods.
-
Digital app for monitoring speech and health in neurodegenerative conditions
This study is testing a digital app that records and analyzes speech to see if it can help monitor and detect neurodegenerative conditions like dementia and Parkinson's disease in both patients and healthy volunteers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.